Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Avalo Therapeutics, Inc. (NASDAQ: AVTX)
AVTX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
239.20%
AVTX Stock Analysis
AVTX
PE Ratio:
AVTX
PEG Ratio:
Not Available
AVTX
Forward EPS Growth (12 month):
0.00%
AVTX
PS Ratio:
2630.2
AVTX
PSG Ratio:
Not Available
AVTX
Forward Revenue Growth (12 month):
0.00%
AVTX Articles
No data was found